HTN:RDN

The definitive Renal Denervation Documentary

Combatting the world’s largest silent killer. This four part documentary series explores the history, the trials and tribulations, the renewed success and the future of Renal Denervation.
Follow the brand Subscribe to Wondr

PIVOTAL TRIAL PRESENTATION

Watch the presentation of the SPYRAL OFF MED Pivotal trial results at ACC.20 with a live panel discussion & responses from the HTN:RDN experts

Watch Now Watch Now Watch Now

DOWNLOAD RESULTS

Spyral RDN Off-Med Trial - DOWNLOAD RESULTS

Download all the results of this pivotal Late Breaker, including:
Trial Results Presentation
Trial Results Slides
Supporting Material
Shareable 1-Pagers
Download

SPYRAL HTN-OFF MED: Expert Reaction Subscribe
View all

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Presentation

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Results Interview GERMAN

DOCUMENTARY

The Definitive Renal Denervation Documentary

Watch Now Watch Now Watch Now

HTN:RDN Documentary Episodes
View all

open video

WONDR

HTN:RDN Episode 1. The History & The Hope

open video

WONDR

HTN:RDN Episode 2. Trials, Technology & Tribulations

open video

WONDR

HTN:RDN Episode 3. Lesson Learned, Effectiveness Regained

open video

WONDR

HTN:RDN Episode 4. A Therapy for Today & Tomorrow

Featured Speakers

David Kandzari


Dr. Kandzari is Director of Interventional Cardiology, Piedmont Heart Institute and Chief Scientific Officer, Piedmont Healthcare. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine.

Follow

Felix Mahfoud


Dr Felix Mahfoud is associate professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital. He is involved in the design and execution of several pharmaceutical and interventional studies in hypertension treatment.

Follow

Joachim Weil


Prof. Dr. Weil is Director of the Cardiovascular center at the Sana Clinic in Lübeck. His clinical focus is interventional therapy of coronary artery disease and arterial hypertension including renal denervation as well chronic heart failure

Follow

Michael Böhm


Dr Böhm is Director of the Klinik für Innere Medizin III and Chief of Cardiology at the University of the Saarland in Homburg/Saar in Germany. He has been the principal investigator in several international multicenter studies.

Follow

Peter Sever


Prof. Peter Sever is Professor of Clinical Pharmacology and Therapeutics at Imperial College London. His research is in the pathophysiology of vascular disease, the evaluation of anti-hypertensive drug therapy and multiple risk factor intervention in hypertensive populations.

Follow

Costas Tsioufis


Dr. Tsioufis, Professor of Cardiology, National and Kapodistrian University of Athens, Director of the Hypertension Unit, 1st Cardiology Clinic, Hippokration Hospital, Athens, Greece. Interventional Cardiologist and Hypertension Specialist.

Follow

Videos
View all

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Results Interview

open video

WONDR

SPYRAL HTN-OFF MED Trial Results Presentation

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Results Interview GERMAN

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Pre-Results Panel Discussion PART 1

open video

WONDR

SPYRAL HTN-OFF MED Pivotal Trial Post-Results Panel Discussion PART 2

open video

EPIC-SEC

Multimarker Risk Score for Risk Prediction

open video

EPIC-SEC

Case Report: Catheter Based Therapy for Hypertension